-
Optical Coherence Tomography Predictors for Recurrent Restenosis After Paclitaxel-Coated Balloon Angioplasty for Drug-Eluting Stent RestenosisMiura K, Tada T, Habara S et al. -
Percutaneous Treatment and Outcomes of Small Coronary Vessels: A SCAAR ReportA Silverio, S Buccheri, G Sarno et al.
-
Drug-Coated Balloon for De Novo Coronary Artery Disease: JACC State-of-the-Art ReviewC Yerasi, BC Case, BJ Forrestal et al.
-
Sustainable Antirestenosis Effect With a Low-Dose Drug-Coated Balloon: The ILLUMENATE European Randomized Clinical Trial 2-Year ResultsM Brodmann, M Werner, the ILLUMENATE EU RCT Investigators.
-
Survival After Coronary Revascularization With Paclitaxel-Coated BalloonsB Scheller, D Vukadinovic, R Jeger et al.
-
Benefits with drug-coated balloon as compared to a conventional revascularization strategy for the treatment of coronary and non-coronary arterial disease: a comprehensive meta-analysis of 45 randomized trialsM Verdoia, F Negro, G De Luca et al.
-
Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent RestenosisD Giacoppo, F Alfonso, B Xu et al.
-
3-Year Clinical Follow-Up of the RIBS IV Clinical Trial A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting StentsF Alfonso, MJ Pérez-Vizcayno, J Cuesta et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
